Mouse models where white adipocyte cholinergic stimulation is enhanced by, for example, deleting adipocyte cholinesterase activity, will hopefully reveal the pathophysiological relevance of the non-neuronal cholinergic system in visceral fat and its potential to be harnessed to combat morbid obesity and metabolic syndrome. This evidence concerns the gene BCHE and metabolic syndrome.